163 related articles for article (PubMed ID: 8794733)
1. Biochemical analysis of catalytically crucial aspartate mutants of human immunodeficiency virus type 1 reverse transcriptase.
Kaushik N; Rege N; Yadav PN; Sarafianos SG; Modak MJ; Pandey VN
Biochemistry; 1996 Sep; 35(36):11536-46. PubMed ID: 8794733
[TBL] [Abstract][Full Text] [Related]
2. Role of glutamine-151 of human immunodeficiency virus type-1 reverse transcriptase in RNA-directed DNA synthesis.
Kaushik N; Harris D; Rege N; Modak MJ; Yadav PN; Pandey VN
Biochemistry; 1997 Nov; 36(47):14430-8. PubMed ID: 9398161
[TBL] [Abstract][Full Text] [Related]
3. Role of methionine 184 of human immunodeficiency virus type-1 reverse transcriptase in the polymerase function and fidelity of DNA synthesis.
Pandey VN; Kaushik N; Rege N; Sarafianos SG; Yadav PN; Modak MJ
Biochemistry; 1996 Feb; 35(7):2168-79. PubMed ID: 8652558
[TBL] [Abstract][Full Text] [Related]
4. Elucidation of the role of Arg 110 of murine leukemia virus reverse transcriptase in the catalytic mechanism: biochemical characterization of its mutant enzymes.
Chowdhury K; Kaushik N; Pandey VN; Modak MJ
Biochemistry; 1996 Dec; 35(51):16610-20. PubMed ID: 8987996
[TBL] [Abstract][Full Text] [Related]
5. Significance of the O-helix residues of Escherichia coli DNA polymerase I in DNA synthesis: dynamics of the dNTP binding pocket.
Kaushik N; Pandey VN; Modak MJ
Biochemistry; 1996 Jun; 35(22):7256-66. PubMed ID: 8679555
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine 222, a member of the YXDD motif of MuLV RT, is catalytically essential and is a major component of the fidelity center.
Kaushik N; Singh K; Alluru I; Modak MJ
Biochemistry; 1999 Mar; 38(9):2617-27. PubMed ID: 10052931
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
Najmudin S; Coté ML; Sun D; Yohannan S; Montano SP; Gu J; Georgiadis MM
J Mol Biol; 2000 Feb; 296(2):613-32. PubMed ID: 10669612
[TBL] [Abstract][Full Text] [Related]
8. Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138.
Pelemans H; Aertsen A; Van Laethem K; Vandamme AM; De Clercq E; Pérez-Pérez MJ; San-Félix A; Velázquez S; Camarasa MJ; Balzarini J
Virology; 2001 Feb; 280(1):97-106. PubMed ID: 11162823
[TBL] [Abstract][Full Text] [Related]
9. Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro.
Ji X; Klarmann GJ; Preston BD
Biochemistry; 1996 Jan; 35(1):132-43. PubMed ID: 8555166
[TBL] [Abstract][Full Text] [Related]
10. 3,5,8-Trihydroxy-4-quinolone, a novel natural inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
Loya S; Rudi A; Tal R; Kashman Y; Loya Y; Hizi A
Arch Biochem Biophys; 1994 Mar; 309(2):315-22. PubMed ID: 7510944
[TBL] [Abstract][Full Text] [Related]
11. Functional roles of carboxylate residues comprising the DNA polymerase active site triad of Ty3 reverse transcriptase.
Bibillo A; Lener D; Klarmann GJ; Le Grice SF
Nucleic Acids Res; 2005; 33(1):171-81. PubMed ID: 15647500
[TBL] [Abstract][Full Text] [Related]
12. Chiral discrimination of enantiomeric 2'-deoxythymidine 5'-triphosphate by HIV-1 reverse transcriptase and eukaryotic DNA polymerases.
Yamaguchi T; Iwanami N; Shudo K; Saneyoshi M
Biochem Biophys Res Commun; 1994 Apr; 200(2):1023-7. PubMed ID: 7513992
[TBL] [Abstract][Full Text] [Related]
13. Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution.
Ding J; Das K; Hsiou Y; Sarafianos SG; Clark AD; Jacobo-Molina A; Tantillo C; Hughes SH; Arnold E
J Mol Biol; 1998 Dec; 284(4):1095-111. PubMed ID: 9837729
[TBL] [Abstract][Full Text] [Related]
14. A role for dNTP binding of human immunodeficiency virus type 1 reverse transcriptase in viral mutagenesis.
Weiss KK; Chen R; Skasko M; Reynolds HM; Lee K; Bambara RA; Mansky LM; Kim B
Biochemistry; 2004 Apr; 43(15):4490-500. PubMed ID: 15078095
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of Lys65 of HIV-1 reverse transcriptase.
Sluis-Cremer N; Arion D; Kaushik N; Lim H; Parniak MA
Biochem J; 2000 May; 348 Pt 1(Pt 1):77-82. PubMed ID: 10794716
[TBL] [Abstract][Full Text] [Related]
16. Substitution of Asp114 or Arg116 in the fingers domain of moloney murine leukemia virus reverse transcriptase affects interactions with the template-primer resulting in decreased processivity.
Gu J; Villanueva RA; Snyder CS; Roth MJ; Georgiadis MM
J Mol Biol; 2001 Jan; 305(2):341-59. PubMed ID: 11124910
[TBL] [Abstract][Full Text] [Related]
17. Refined model for primer/template binding by HIV-1 reverse transcriptase: pre-steady-state kinetic analyses of primer/template binding and nucleotide incorporation events distinguish between different binding modes depending on the nature of the nucleic acid substrate.
Wöhrl BM; Krebs R; Goody RS; Restle T
J Mol Biol; 1999 Sep; 292(2):333-44. PubMed ID: 10493879
[TBL] [Abstract][Full Text] [Related]
18. Loss of polymerase activity due to Tyr to Phe substitution in the YMDD motif of human immunodeficiency virus type-1 reverse transcriptase is compensated by Met to Val substitution within the same motif.
Harris D; Yadav PN; Pandey VN
Biochemistry; 1998 Jul; 37(27):9630-40. PubMed ID: 9657675
[TBL] [Abstract][Full Text] [Related]
19. Alterations to the primer grip of p66 HIV-1 reverse transcriptase and their consequences for template-primer utilization.
Ghosh M; Jacques PS; Rodgers DW; Ottman M; Darlix JL; Le Grice SF
Biochemistry; 1996 Jul; 35(26):8553-62. PubMed ID: 8679616
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the p68/p58 heterodimer of human immunodeficiency virus type 2 reverse transcriptase.
Fan N; Rank KB; Poppe SM; Tarpley WG; Sharma SK
Biochemistry; 1996 Feb; 35(6):1911-7. PubMed ID: 8639674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
